Meeting
2018 Palliative and Supportive Care in Oncology Symposium
Discontinuation of poly(adenosine diphosphate-ribose) polymerase inhibitors due to adverse events in patients with recurrent ovarian cancer: A meta-analysis of three phase III trials.
Authors
Kyaw Zin Thein
University of Texas MD Anderson Cancer Center, Houston, TX
Kyaw Zin Thein, Anita Sultan, Myo Zaw, Sriman Swarup, Myat M. Han, Yin Mon Myat, Catherine Jones, Fred L. Hardwicke, Sanjay Awasthi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Communication and Shared Decision Making; Integration and Delivery of Palliative and Supportive Care; and Psychosocial and Spiritual/Cultural Assessment and Management
Track
Integration and Delivery of Palliative and Supportive Care,Communication and Shared Decision Making,Psychosocial and Spiritual/Cultural Assessment and Management
Sub Track
Integration and Delivery of Palliative and Supportive Care
Citation
J Clin Oncol 36, 2018 (suppl 34; abstr 118)
DOI
10.1200/JCO.2018.36.34_suppl.118
Abstract #
118
Poster Bd #
E6
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Risk of secondary hematologic malignancies in patients with ovarian cancer treated with PARP inhibitors: A combined meta-analysis of seven phase III randomized controlled trials.
First Author: Thura Htut
Poster
2018 Palliative and Supportive Care in Oncology Symposium
Risk of gastrointestinal and hepatic toxicities in patients with cancer treated with poly adenosine diphosphate ribose polymerase inhibitors: A meta-analysis of seven phase III trials.
First Author: Myo Zaw
Poster
2022 ASCO Genitourinary Cancers Symposium
Differential efficacy of PARP inhibitors in metastatic castration-resistant prostate cancer with DNA repair defects: A systematic review and meta-analysis.
First Author: Syed Arsalan Ahmed Naqvi
Poster
2018 Palliative and Supportive Care in Oncology Symposium
Risk of health-related quality-of-life events and pulmonary toxicities in patients with cancer treated with poly adenosine diphosphate ribose polymerase inhibitors: A meta-analysis of seven phase III trials.
First Author: Sriman Swarup